Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biohope is a private Spanish biotechnology and in vitro diagnostics company focused on precision medicine for immunosuppression and autoimmune conditions. Its core technology, Immunobiogram, is a patented blood-based diagnostic platform that measures how a patient's immune cells respond to immunosuppressive or immunomodulatory therapies, with the goal of personalizing treatment selection and dosing. The company's lead commercial product is Immunobiogram for renal transplant, which is CE-marked and supported by clinical studies. Biohope is also extending the platform into autoimmune diseases, including rheumatoid arthritis and lupus nephritis, and is developing tests aimed at predicting response to methotrexate, JAK inhibitors, and biologic therapies. The company positions itself as an IVD innovator building a broader portfolio for immune-based indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biohope Scientific Solutions.